The landscape of bispecific T cell engager in cancer treatment by Shujie Zhou, Mingguo Liu, Fei Ren, Xiangjiao Meng, Jinming Yu

Subjects: Get full text

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies by Joshua D Freedman, Joachim Hagel, Eleanor M Scott, Ioannis Psallidas, Avinash Gupta, Laura Spiers, Paul Miller, Nikolaos Kanellakis, Rebecca Ashfield, Kerry D Fisher, Margaret R Duffy, Leonard W Seymour

Subjects: Get full text

Extracellular vesicle surface display of αPD‐L1 and αCD3 antibodies via engineered late domain‐based scaffold to activate T‐cell anti‐tumor immunity by Rui Chen, Ziqin Kang, Wenhao Li, Tianshu Xu, Yongqiang Wang, Qiming Jiang, Yuepeng Wang, Zixian Huang, Xiaoding Xu, Zhiquan Huang

Subjects: “…bispecific T‐cell engager…”
Get full text

Recent advances on blinatumomab for acute lymphoblastic leukemia by Juanjuan Zhao, Yongping Song, Delong Liu

Subjects: Get full text

Engineering Bifunctional Calcium Alendronate Gene‐Delivery Nanoneedle for Synergistic Chemo/Immuno‐Therapy Against HER2 Positive Ovarian Cancer by Guochuang Chen, Leli Zeng, Bo Bi, Xiuyu Huang, Miaojuan Qiu, Ping Chen, Zhi‐Ying Chen, Yulong He, Yihang Pan, Yu Chen, Jing Zhao

Subjects: Get full text

The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use by Rita Tavarozzi, Enrica Manzato

Subjects: Get full text

Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies by Zheng Tian, Ming Liu, Ya Zhang, Xin Wang

Subjects: “…Bispecific T cell engager…”
Get full text

Oncolytic adenovirus coding for bispecific T cell engager against human MUC-1 potentiates T cell response against solid tumors by Saru Basnet, Joao M. Santos, Dafne C.A. Quixabeira, James H.A. Clubb, Susanna A.M. Grönberg-Vähä-Koskela, Victor Arias, Santeri Pakola, Tatiana V. Kudling, Camilla Heiniö, Riikka Havunen, Victor Cervera-Carrascon, Suvi Sorsa, Marjukka Anttila, Anna Kanerva, Akseli Hemminki

Subjects: Get full text

A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer by Caterina Riillo, Nicoletta Polerà, Maria Teresa Di Martino, Giada Juli, Craig A. Hokanson, Tatjana Odineca, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Antonia Mancuso, Nicoletta Staropoli, Basilio Caparello, Maria Cerra, Giuseppe Nisticò, Pierosandro Tagliaferri, Roberto Crea, Daniele Caracciolo, Pierfrancesco Tassone

Subjects: Get full text

A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity by Yan Feng, Kun Xie, Yanxin Yin, Bingyu Li, Chenyu Pi, Xiaoqing Xu, Tao Huang, Jingming Zhang, Bo Wang, Hua Gu, Jianmin Fang

Subjects: Get full text

First report of teclistamab in a patient with relapsed AL amyloidosis and multiple myeloma by Nelson Leung, Jennifer A Chapman, Sumeet Bhatia

Subjects: Get full text

Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus by Hanna Menschikowski, Christopher Bednar, Sabrina Kübel, Manuel Hermann, Larissa Bauer, Marco Thomas, Arne Cordsmeier, Armin Ensser

Subjects: Get full text

Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies by Margaux Lejeune, Murat Cem Köse, Elodie Duray, Hermann Einsele, Yves Beguin, Yves Beguin, Jo Caers, Jo Caers

Subjects: Get full text

Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers by Scott A. Becker, Brian G. Petrich, Bing Yu, Kristopher A. Knight, Harrison C. Brown, Sunil S. Raikar, Christopher B. Doering, H. Trent Spencer

Subjects: Get full text

Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager by Jana de Sostoa, Carlos Alberto Fajardo, Rafael Moreno, Maria D. Ramos, Martí Farrera-Sal, Ramon Alemany

Subjects: Get full text

Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors by Min Wei, Min Wei, Shuguang Zuo, Zhimin Chen, Peng Qian, Peng Qian, Yenan Zhang, Yenan Zhang, Lingkai Kong, Lingkai Kong, Honglan Gao, Jiwu Wei, Jiwu Wei, Jie Dong, Jie Dong

Subjects: Get full text

Population dynamics of immunological synapse formation induced by bispecific T cell engagers predict clinical pharmacodynamics and treatment resistance by Can Liu, Jiawei Zhou, Stephan Kudlacek, Timothy Qi, Tyler Dunlap, Yanguang Cao

Subjects: Get full text

Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update by Roa Alsajjan, Warren P. Mason

Subjects: Get full text

Current landscape and future directions of bispecific antibodies in cancer immunotherapy by Jing Wei, Yueyao Yang, Gang Wang, Ming Liu

Subjects: Get full text

Bispecific antibodies in multiple myeloma treatment: A journey in progress by Shih-Feng Cho, Shih-Feng Cho, Shih-Feng Cho, Tsung-Jang Yeh, Kenneth C. Anderson, Yu-Tzu Tai

Subjects: Get full text